Wednesday, 17 January 2018
Latest news
Main » Boston Scientific Corporation (BSX) SVP Sells 8763 Shares of Stock

Boston Scientific Corporation (BSX) SVP Sells 8763 Shares of Stock

14 January 2018

Eaton Vance Management now owns 3,907,561 shares of the company's stock valued at $91,320,000 after buying an additional 3,880,232 shares during the period. The total amount of shares outstanding is 1.37 billion, giving the company a market capitalization of about 38.36 billion. The stock increased 1.39% or $1.58 during the last trading session, reaching $115.05. As a result results using moving averages can be random at times the market appears to respect SMA support/resistance and trade signals, and other times it shows no deference. It has outperformed by 80.12% the S&P500.

Evercore Trust Company decreased Boston Scientific Corp (BSX) stake by 3.58% reported in 2017Q3 SEC filing. Cullinan Assocs Incorporated accumulated 198,602 shares or 0.82% of the stock.

Several other institutional investors have also bought shares of the company. The firm's quarterly revenue was up 5.6% on a year-over-year basis. analysts predict that Boston Scientific will post 1.25 EPS for the current year. The stock decreased 1.57% or $0.44 during the last trading session, reaching $27.52. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 14, 2017 and is uptrending. It has outperformed by 2.42% the S&P500. Shares for $208,328 were sold by Sorenson John Bradley. Pierce David A sold 8,763 shares worth $243,074. (NYSE:TREX) or 285,875 shares.

Of those holders, 237 had increased positions amounting to 50.69 million shares, 247 had decreased positions amounting to 44.32 million shares, and 103 holders have a held position accounting for 1.2 billion shares.

More news: Ethiopia to release all political prisoners

Boston Scientific (BSX) traded down $0.23 on Friday, hitting $25.14. Teacher Retirement System Of Texas acquired 127,112 shares as Ecolab Inc (ECL)'s stock rose 2.53%. (NASDAQ:ASTE). Patten Grp Inc accumulated 0.02% or 25 shares. 308,705 were reported by Brown Advisory Inc. Institutional investors own 90.36% of the company's stock. (NYSE:C). Columbia Prtnrs L L C Investment invested 0.29% in Citigroup Inc. Private Advisor Gp Ltd Liability Corp has 18,863 shares for 0.01% of their portfolio.

The Company now has ROA (Return on Assets) of 22.2 percent, Return on Equity (ROE) of 24.6 Percent and Return on Investment (ROI) of 17.1% with Gross margin of 86.6 percent and Operating & Profit margin of 47.7% and 43.6% respectively. Oppenheimer & Company invested 0.86% of its portfolio in General Electric Company (NYSE:GE). White Elm Ltd owns 282,100 shares or 4.06% of their USA portfolio. Great West Life Assurance Can stated it has 991,691 shares or 0.07% of all its holdings. The California-based National Planning Corporation has invested 0.04% in Ecolab Inc. (NYSE:ECL) for 448,113 shares. Grp One Trading Limited Partnership stated it has 194,355 shares. Terril Brothers reported 361,601 shares. Exchange Capital invested in 472 shares. Principal Group Inc reported 144,837 shares.

Susquehanna International Group Llp increased Alps Etf Tr (Put) (AMLP) stake by 175,400 shares to 278,800 valued at $3.13M in 2017Q3.

Analysts await Sarepta Therapeutics, Inc. Everence Management reported 0.19% of its portfolio in Boston Scientific Corporation (NYSE:BSX). They expect $0.34 earnings per share, up 13.33% or $0.04 from last year's $0.3 per share. BSX's profit would be $466.89 million giving it 20.19 P/E if the $0.34 EPS is correct. After $0.29 actual earnings per share reported by General Electric Company for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

More news: Tottenham 4-0 Everton: Harry Kane becomes Spurs' record Premier League goalscorer

Among 9 analysts covering Trex Co (NYSE:TREX), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 67% are positive. General Electric Company had 81 analyst reports since July 21, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with "Hold" rating and $58 target in Wednesday, November 9 report. On Monday, August 10 the stock rating was reinitiated by Credit Suisse with "Outperform". The stock has "Hold" rating by Oppenheimer on Monday, May 1. As per Wednesday, August 26, the company rating was upgraded by Vetr. The firm has "Buy" rating by BTIG Research given on Thursday, November 30. The rating was maintained by RBC Capital Markets with "Buy" on Sunday, November 5. On Monday, September 28 the stock rating was upgraded by Global Hunter Securities to "Accumulate". Leerink Swann maintained the shares of BSX in report on Tuesday, January 9 with "Buy" rating. The rating was maintained by Morgan Stanley with "Underweight" on Thursday, October 19.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.25, from 0.94 in 2017Q2. It improved, as 33 investors sold Boston Scientific Corporation shares while 166 reduced holdings. 63 funds opened positions while 84 raised stakes. 5 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. Putnam Invs Limited Liability holds 17,374 shares. State Board Of Administration Of Florida Retirement System invested in 0.16% or 1.97M shares. Voya Invest Management Lc holds 0% of its portfolio in Trex Company, Inc. Guardian Life Insur Of America owns 3,178 shares for 0.01% of their portfolio. Pnc Service Group Inc owns 2,312 shares. Caisse De Depot Et Placement Du Quebec holds 22,126 shares. Gotham Asset Ltd Limited Liability Company holds 0.01% in Boston Scientific Corporation (NYSE:BSX) or 28,643 shares. (NASDAQ:ASTE). State Of New Jersey Common Pension Fund D accumulated 1.49 million shares. (NYSE:BSX) last released its quarterly earnings data on Wednesday, October 26th. Sumitomo Mitsui Asset Ltd holds 167,112 shares or 0.08% of its portfolio.

Since August 1, 2017, it had 0 buys, and 11 sales for $14.78 million activity. Also, EVP Timothy A. Pratt sold 10,000 shares of the business's stock in a transaction on Wednesday, November 1st. Shares for $445,137 were sold by Phalen Michael P. on Friday, September 29. Currently, Boston Scientific Corporation (NYSE:BSX) has an average volume of 8.98 Million. Shares for $10.11M were sold by Bose Supratim. 57,031 shares valued at $1.56M were sold by Nanavaty Maulik on Wednesday, August 30. Shares for $270,131 were sold by Gupp William R. Posey Richard E sold $253,360 worth of stock.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

More news: There's Already A Ridiculous $550+ Limited Edition For Dark Souls Remastered